Analysis of clinical trial of orphan drugs and participants medication guarantee
XUAN Si-yu
ZANG Yun-sen
TIAN Kan
Abstract：A small number of rare patients, high cost of clinical trials, lack of supportive resources and other causes make orphans clinical trials to face a lot of obstacles, thus patients cannot get effective treatment. This paper analyzes the present situation of orphan drug clinical trials and the relevant international origin of the drug therapy of the participants after orphan drug clinical trials. On this basis, this paper makes the ethical examination of the orphan drug clinical trials and the medication guarantee of participants, then puts forward the suggestions.This paper aims to provide theoretical reference for the relevant departments of the country to make decision and promote the implementation of our rare disease health care system.
Keywords：rare diseaseorphan drugclinical trialsmedication guarantee
Publication Date：2018-01-01
Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)
Pages：4( 1882-1885 )